Spermosens AB (publ) (NGM:SPERM)

Market Cap	29.82M +168.1%
Revenue (ttm)	n/a
Net Income	-9.31M
EPS	-0.00
Shares Out	3.17B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,620,588
Open	0.0096
Previous Close	0.0096
Day's Range	0.0086 - 0.0098
52-Week Range	0.0042 - 0.0138
Beta	0.14
Analysts	n/a
Price Target	n/a
Earnings Date	May 7, 2026

About Spermosens AB

Spermosens AB (publ) provides diagnostic health care products and services in Sweden. The company offers devices for male infertility for fertility diagnostics and treatments for the IVF market. It develops JUNO-Checked, a device that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. Spermosens AB (publ) was incorporated in 2018 and is headquartered in Lund, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2018
• Employees: 4
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: SPERM